A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)

Clinical trial NCT05472259 · RECRUITING

Trial details

NCT number: NCT05472259
Sponsor: Belgian Group of Digestive Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2022-05-25
Primary completion: 2026-12-31
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.